Skip to main content

More cuts to come at Ludwigshafen

26th February 2024

Submitted by:

Andrew Warmington

In its annual results presentation, BASF announced plans to reduce costs at its main verbund site in Ludwigshafen by a further €1 billion/year by the end of 2026. This comes on top of a similar scale of cuts initiated in late 2022.

Last year, results in Germany suffered due to substantially negative earnings at Ludwigshafen, the company said. This was attributed to two main causes: the temporary low-demand environment is affecting volume development both upstream and downstream, while structurally high energy prices are raising production costs upstream.

The cost reduction programme will target production and non-production areas. BASF will seek to adapt production capacities to market needs and significantly trim variable costs by redesigning processes. It will also endeavour to improve utilisation rates, which are “considerably below normal levels”. There will be an as yet unspecified number of job cuts.

The board expects to present a target picture in 2H 2024, based on the regulatory framework and the changed market realities in Europe and Germany. Board chairman Martin Brudermüller said: “The board team will remain strongly committed to the Ludwigshafen site. We want to develop Ludwigshafen into the leading low-CO2-emission chemical production site with high profitability and sustainability.”

BASF saw sales fall from €87.3 billion to €68.9 billion in the 2023 business year, mainly driven by considerably lower prices and volumes. Sales volumes fell in all segments as a result of weak demand. However, it managed to increase cash flows from operating activities by 5.2% to €8.1 billion.

EBIT before special items fell from €6.9 billion in 2022 to €3.8 billion, primarily due to a considerably lower earnings contribution from the Chemicals and Materials segments. Only the Agricultural Solutions business really bucked this trend. The company also saw a big fall in EBIT to €2.2 billion because of various impairments on property, plant and equipment and on tangible and intangible assets.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington